Effect of 99mTc-MDP administration on dual-energy X-ray absorptiometry bone mineral density measurements.

The effect of a diagnostic dose of (99m)Tc-MDP on bone mineral density (BMD) estimations in the lumbar spine and the neck of femur was assessed in 20 patients using a Hologic QDR4500 scanner. Each patient underwent a DXA assessment prior to and 1 h following injection of (99m)Tc-MDP (mean dose-910 MBq). For comparative purposes, the precision of BMD estimation without the presence of a radioisotope was assessed by performing two sequential DXA studies on 30 volunteers and was found to be less than 0.01 g/cm(2). No significant change in BMD reading was detected following (99m)Tc-MDP injection for either measurement site and the precision of the readings was similar to that observed for the 30 volunteers. This study has shown that any effect produced by a typical bone scan dose of (99m)Tc-MDP is small in comparison with the intrasubject variance when estimating BMD using a Hologic QDR4500 scanner.     

Influence of patient's weight on dual-photon absorptiometry and dual-energy X-ray absorptiometry measurements of bone mineral density

Lumbar spine bone mineral density (BMD) was measured by dual-energy X-ray absorptiometry (DXA) (Hologic QDR 1000) and by¹⁵³Gd dual-photon absorptiometry (DPA) (Novo Lab 22a) in 120 postmenopausal women. Though a high correlation existed between the two techniques, the ratio between DXA and DPA values was not constant. Using DXA we observed a higher dependence of BMD on weight than in the DPA measurements. To investigate the different behaviour of DXA and DPA machines with weight, we analysed the effects of increasing thickness of soft tissue equivalents on the BMD of the Hologic spine phantom and on the BMD equivalent of an aluminium standard tube. Increasing tissue-equivalent thickness caused the phantom BMD measured by DPA to decrease significantly but had not effect on the DXA measurements. The different behaviour of DPA and DXA equipment with regard to the phantoms could account for the differences observed in the relations between BMD and weight in the patients. Using multiple regression we studied the influence of weight and body mass index on the relation between BMD measured by the two techniques. The introduction of either of these variables into the regression resulted in an improvement of the prediction of the DXA values from the DPA values. However, the residual standard error of the estimate was still higher than the combined precision errors of the two methods, so that no simple relation allows a conversion of BMD_DPA into BMD_DXA. Our results confirm that BMD is positively correlated with weight in postmenopausal women; the influence of weight on BMD is blunted when the Novo Lab 22a DPA machine is used for measuring bone mineral.     

Vertebral bone mineral density measured laterally by dual-energy X-ray absorptiometry

The bone mineral density (BMD) of lumbar vertebrae in the anteroposterior (AP) view may be overestimated in osteoarthritis or with aortic calcification, which are common in elderly. Furthermore, the risk of spinal crush fracture should be more closely related inversely to the BMD of the vertebral body than to that of the posterior arch. Therefore, we measured BMD of lumbar vertebrae in lateral (LAT) view (L2–L3), using a standard dual-energy X-ray absorptiometer (DEXA), thus eliminating most of the posterior spinal elements. The precision of BMD LAT measurement was determined both in vitro and in healthy volunteers. Then, we compared the capability of BMD LAT and BMD AP scans for monitoring bone loss related to age and for discriminating the BMD of postmenopausal women with nontraumatic vertebral fractures from that of young subjects. In vitro, when a spine phantom was placed in lateral position in the middle of 26 cm of water in order to simulate both soft-tissue thickness and X-ray source remoteness, the coefficient of variation (CV) of six repeated determinations of BMD was 1.0%. In vivo, the CV of paired BMD LAT measurements obtained in 20 healthy volunteers after repositioning was 2.8%. The age-related difference between a peak bone mass group estimated in a group of 27 healthy women aged 20 to 35 years and a group of 50 women aged 60 to 75 years, in whom neither vertebral fracture nor osteoporosis risk factors could be detected, were 21.7% and 37.6% in AP and LAT view, respectively. An arbitrary BMD fracture threshold was defined in AP and LAT views as the 90th percentile of the BMD value of a group of 22 osteoporotic women with vertebral fractures. The distribution of BMD AP and LAT above and below this threshold in 169 consecutively screened women without vertebral fracture was then analysed. In both AP and LAT views, 39.1% and 31.3% had BMD values above and below this threshold, respectively. Of the remaining, 16.0% had a BMD below this threshold only in AP and 13.6% only in LAT view. Thus, if BMD LAT was a better reflection of vertebral body bone mass than BMD AP, and thereby a better predictor of the resistance to crush fracture, our results would suggest that only the use of the standard AP view could under- or overestimate spinal fracture risk in about 30% of women screened for osteoporosis. In conclusion, our results indicate that BMD measurement in lateral view is feasible with a standard DEXA instrument. This mode of scanning, besides overcoming artefacts due to osteoarthritis of the posterior arch and aortic calcifications, appears to provide a greater sensitivity for assessing bone mass loss of the vertebral body than the standard anteroposterior scan.     

股骨近端骨密度的测量

双能X线骨密度仪检测骨密度是诊断骨质疏松症和疗效随访的金标准,特别是髋部骨密度的测量对于骨折的预测尤其测定部位本身骨折的预测作用较大.由于脊柱部位的骨密度测量值易受到脊柱退行性疾病的病理改变如退行性侧凸、骨赘增生、腰椎间盘突出等影响,测量的准确性下降.因而近年来欧美国家临床试验也好或者骨质疏松诊疗也好,大都以股骨近端的BMD测定为标准.本文就股骨近端解剖特点、骨密度测量的意义、方法以及测量的注意点作一个综述,以期帮助临床医生或技术员全面评估股骨近端骨密度测定的意义.     

Inaccuracies inherent in dual-energy X-ray absorptiometry in vivo bone mineral densitometry may flaw osteopenic/osteoporotic interpretations and mislead assessment of antiresorptive therapy effectiveness

New, anatomically realistic simulation studies based on a cadaveric lumbar vertebra and a broad range of soft tissue anthropometric representations have quantitatively delineated inaccuracies inherent in dual-energy X-ray absorptiometry (DXA) in vivo bone mineral density (BMD) methodology. It is found that systematic inaccuracies in DXA BMD measurements may readily exceed +/-20% at typical in vivo lumbar vertebral sites, especially for osteopenic/osteoporotic, postmenopausal, and elderly patients. These findings are quantitatively compared with extensive clinical evidence of strong, positive correlations between soft tissue anthropometrics and DXA in vivo BMD upon which prior significant bone biology interpretations and implications have been based. The agreement is found to be both qualitatively and quantitatively excellent. Moreover, recent extensive multicenter clinical studies have also exposed new facets of strong linkages between body mass/percent body fat/body mass index (BMI) and DXA-measured BMD that are particularly relevant to osteopenia/osteoporosis and remedial effectiveness of antiresorptive drug therapy. These seemingly disparate and unrelated diagnostic and prognostic aspects of clinically observed associations between soft tissue anthropometrics and measured vertebral BMD are, in this study, self-consistently shown to share the common origin of being manifestations of systematic inherent inaccuracies in DXA in vivo BMD methodology, without the need to invoke any underlying biologically causal mechanism(s). These inaccuracies arise principally from absorptiometric disparities between the intra- and extraosseous soft tissues within the DXA scan region of interest. The present evaluative comparisons are based exclusively on an incisive and diverse body of clinical data that appears difficult to dismiss or discount. Previous invocations of biologically causal mechanisms responsible for this broad range of observations linking body mass, percent body fat, and/or BMI to measured BMD now appear questionable. This doubtful status has also been extended in the present work to previously reported relationships between antiresorptive therapies and observed changes in DXA-derived BMD. These findings strongly indicate that critical and insightful reassessments of diagnostic/prognostic imputations underpinned by DXA in vivo BMD measurements are warranted. It is suggested that a good deal of what is known of bone fragility, bone densitometry, antiresorptive drug efficacy, and/or other therapeutic regimens, if based on patient-specific in vivo DXA methodology, may prove to be equivocal and tenuous.     

甘肃兰州地区491例双能X线骨密度测定分析

目的 了解兰州地区正常人群腰椎，髋部骨密度（BMD）的年龄变化规律，为当地骨质疏松诊断提供科学依据。方法 2000年9月－2002年7月，采用法国DMS公司生产的Challenger双能量X线骨密度仪（DEXA）测量年龄在20－89岁之间的491例正常人L2－L4椎体前后位和左髋部BMD，获得的数据录入SPSS软件数据库，并进行有关统计分析。结果 男女两性BMD在30岁左右达到峰值，约在40岁左右开始减低，其中女性在50岁后下降速度加快，但男性腰椎BMD随年龄的增高下降并不明显。结论 BMD达峰值后随年龄增加而减低，但在男性腰椎这一趋势并不明显。     

Comparison and investigation of bone mineral density in opposing femora by dual-energy X-ray absorptiometry

A dual-energy X-ray absorptiometry (DXA) machine was used to measure the bone mineral density (BMD) of both femora in 760 female volunteers. Each volunteer completed a questionnaire and exclusion criteria were applied such that only 480 of these were considered normal subjects. The remaining 280 women failed to comply with the criteria and were considered abnormal; their BMD results were analysed separately. Two abnormal subgroups, one with previous long bone fractures and one with radiologically diagnosed osteopenia, were studied. BMD values for femoral neck, Ward's triangle and trochanter were compared between the two femora in all the above groups. No dominance relationship was found when comparing left to right femur, averaged over any population studied, but large differences were found between the femora in individual volunteers. There was a high correlation between BMD in opposing femora of 0.91, 0.91 and 0.84 for the femoral neck, Ward's triangle and trochanter respectively. However, in normal subjects the percentage variation in these regions ranged up to 34%, 64% and 80% respectively at the different femoral sites. In addition, the normal population was divided into two subgroups, one in which the density difference between the femora was large, and the other in which the difference was statistically insignificant. The analytical and anatomical variations between these two groups were investigated. Only part of the difference appeared to be due to analytical problems and it seems that there is a genuine difference in femoral density. Poor correlation for femoral neck percentage density difference was found with average BMD, age, height and weight in the normal population. This study concludes that a measurement of BMD in one femur can not reliably predict the BMD in the contralateral femur. It is therefore recommended that routine density measurements should include scanning of both femora.     

Precision and accuracy of measuring changes in bone mineral density by dual-energy X-ray absorptiometry

Summary Long-term precision of two Hologic DXA scanners was derived from repeated clinical measurements. With typical subjects, the long-term coefficients of variation were about twice the short-term. The accuracy of the measurement of changes was compromised by anomalies, but this did not seriously affect clinical conclusions. Introduction Long-term precision and accuracy of BMD measurements need review. Methods Long-term precision was examined by selecting, from Hologic databases, subjects who had had four scans over a period of 2 to 5 years and was calculated from the SEE of a regression of BMD against time. Accuracy was assessed from relationships between changes (Δ) in BA, BMD and BMC. Results For one group of subjects, the long-term precision was 2.4% for lumbar spine, 2.3% for total hip and 2.7% for femoral neck when expressed as CVs. These values were nearly twice the short-term CVs of 1.3% for spine, 1.2% for total hip and 1.4% for femoral neck. For another group, a negative exponential regression gave a better fit, leading to CVs of 1.3% for the spine, 1.4% for total hip and 2.1% for femoral neck. Significant correlations between ΔBA and ΔBMC were found. These led to an underestimate of ΔBMD in spine and hip by 25%. Conclusions The poorer long-term precision for typical patients should be borne in mind in monitoring progress. The underestimate of changes could account for only a part of the underestimation by BMD measurements of the anti-fracture effects of anti-resorptive drugs.     

Validation and application of dual-energy X-ray absorptiometry to measure bone mineral density in rabbit vertebrae.

The rabbit could be a superior animal model to use in bone physiology studies, for the rabbit does attain true skeletal maturity. However, there are neither normative bone mineral density (BMD) data on the rabbit nor are there any validation studies on the use of dual-energy X-ray absorptiometry (DXA) to measure spinal BMD in the rabbit. Therefore, our aim was twofold: first, to investigate whether DXA could be used precisely and accurately to determine the bone mineral content (BMC). bone area (BA). and BMD of the rabbit lumbar spine: Second. to evaluate the new generation fan-beam DXA (Hologic QDR-4500) with small animal software by comparing two DXA methodologies QDR-1000 and QDR-4500 with each other, as well as against volumetric bone density (VBMD) derived from Archimedes principle. As expected. there was a magnification error in the QDR-4500 (BMC, BA. and BMD increased by 52%. 38%. and 10%, respectively, when the vertebrae were positioned flat against the scanning table). With the magnification error kept constant (vertebrae positioned 10 cm above the scanning table to match the height in vivo). there were no differences among the mean BMC. BA. and BMD of the rabbit vertebrae (Ll-L7) in vivo and in vitro using the QDR-4500 (p > 0.05). BMC, BA, and BMD differed between QDR-1000 and QDR-4500 in vitro because of a magnification error when the vertebrae were flat on the table (p <0.0001). and, consequently. the machines did not correlate with one another (p > 0.05). However, the BMC, BA, and BMD of the two DXAs did significantly correlate with each other in vivo and in vitro when the magnification error was compensated for (r = 0.44 and 0.52. i2 = 0.45 and 0.63. and 12 = 0.41 and 0.60. respectively. p < 0.05-0.008). The BMC and BMD (in vivo and in vitro) of the rabbit vertebrae measured by QDR-4500 was significantly correlated with VMBD, ash weight, and mineral content (,2 = 0.67-0.90,j <0.01-0.0001). Therefore, the QDR-4500 can be used to yield precise and accurate measurements of the rabbit spine.     

Accuracy and precision of in vivo bone mineral measurements in sheep using dual-energy X-ray absorptiometry

We evaluated the precision and accuracy of in vivo measurements of spine bone mineral density (BMD) and bone mineral content (BMC) in five ewes using dual-energy X-ray absorptiometry (DXA, Lunar DPX-L). The short-term in vivo reproducibility expressed as the coefficient of variation (CV) varied from 0.9 to 1.6% for spine BMD and from 1 to 3.1% for spine BMC. The ex vivo measurements, performed in 20 cm of water to simulate soft tissue thickness, correlated closely with the in vivo measurements, yielding an r value of 0.98 and 0.97 for spine BMD and BMC, respectively. The accuracy was determined by comparing the total BMC of each vertebra measured in vivo with the corresponding ash weight. The correlation coefficient between the two measurements was r = 0.98, with an accuracy error of 5.6%. We concluded that the DXA allows a precise and accurate measurement of spine bone mineral in live ewes using the methodology designed for humans. Received: 19 March 1999 / Accepted: 26 July 1999     

Measurement of bone mineral density by dual-energy X-ray absorptiometry around an uncemented knee prosthesis

Dual-energy x-ray absorptiometry allows the measurement of bone mineral density (BMD) around an uncemented hip prosthesis, but has not so far been widely used to measure BMD around a knee prosthesis. We studied 16 patients undergoing total knee replacement using a Miller-Galante uncemented prosthesis for either osteoarthritis or rheumatoid arthritis of the knee. The precision of the measurement was improved by using a leg brace. The pattern of bone loss differed in the lateral projection by region (P = .001). There was significant loss of bone from the distal femur but not from the patella or proximal tibia over the 6-month period after insertion of a knee prosthesis.     

Accuracy and precision of bone mineral density and bone mineral content in excised rat humeri using fan beam dual-energy X-ray absorptiometry.

The aim of this study was the evaluation of fan beam dual-energy X-ray absorptiometry (DXA) for measuring bone mineral density (BMD) and bone mineral content (BMC) of isolated rat humeri. Defleshed rat humeri from male Lewis rats were examined with a Hologic QDR 4500 A (Hologic, Inc., Bedford, MA) high-resolution densitometer both in water and 0.9% saline solution. The small animal scan protocol with the regional high-resolution mode was used. BMC measured by DXA was compared with bone dry weight, ash weight, and bone calcium content. Furthermore, DXA BMD and BMC precision were determined. We also evaluated the effect of salinity of the water bath in which the bones were measured. Correlations (r(2)) of BMC, as determined by DXA with dry weight, ash weight, and bone calcium content, were 0.978, 0.988, and 0.890, respectively. DXA overestimated ash weight by 5%-9%. Precision errors for BMC (BMD) were 0.90% (0.76%) without and 1.3 (0.86) with repositioning. Changes in the salinity of the water bath had a significant influence on the DXA results: At the 0.9% physiological level, BMC (-4.4%) and area (-4.1%), but not BMD, values were significantly lower (p < 0.005) compared with measurements in tap water. Fan beam DXA is a highly accurate and precise technique for measuring BMC and BMD in excised small animal bones. A physiological saline concentration in the water bath had a significant impact on BMC and area, but not on BMD, and should therefore be strictly controlled to avoid an underestimation of BMC.     

Establishment of age-specified bone mineral density reference range for Indian females using dual-energy X-ray absorptiometry

We undertook this study to establish age-specified bone mineral density (BMD) reference range for Indian females using dual-energy X-ray absorptiometry. BMD at multiple skeletal sites was measured in 2034 healthy women aged 18--85yr. The effect of anthropometry and biochemical parameters on BMD was determined. Peak BMD was observed between 30 and 35yr at the hip, lumbar spine, and radius. Significant positive correlation of height and weight with BMD was observed at 33% radius, femur neck, and lumbar spine, whereas significant negative correlation was seen between serum alkaline phosphatase (ALP) and serum parathyroid hormone levels with BMD at aforementioned sites. On multivariate regression analysis, age, weight, and serum ALP were the most consistent contributors to variance in the BMD. Compared with age-matched US females, BMD of lumbar spine was significantly lower for our subjects in all age groups. Prevalence of osteoporosis among women aged older than 50yr was significantly higher based on Caucasian T-scores as opposed to using peak BMD/standard deviation values from the population under review at lumbar spine but not at femoral neck.     

Bone mineral density measured by dual-energy X-ray absorptiometry in healthy finnish women

Summary A cross-sectional study of 351 healthy Finnish women aged 20–76 years was done to establish reference values of bone mineral density (BMD) using dual-energy X-ray absorptiometry (DEXA). The effects of age and of several physical and lifestyle factors on BMD of the lumbar spine and proximal femur (femoral neck, trochanter, and Ward's triangle area) were investigated. Altogether 58 women were excluded from the final analysis due to significant spinal osteoarthritis or other diseases or drugs known to influence calcium or bone metabolism. The precision of the method was 0.9, 1.2, 2.7, and 2.4% in the lumbar, femoral neck, Ward's triangle and trochanter area, respectively. Lumbar BMD was increased by 30% (P<0.001) in 15 patients with osteoarthritis (21% of women 50 years or older), but it was apparently unaffected in 5 cases with aortic calcification. Except for the trochanter area, BMD diminished along with age, and this was significant after the menopause. The peak of mean BMD was observed at the age of 31–35 years in the spine and at the age of 20–25 years in the femoral neck and Ward's triangle. BMD was in a positive relationship to weight both in premenopausal and postmenopausal women and to the use of oral contraceptives in premenopausal women and to that of estrogen replacement therapy in postmenopausal women. Labors and pregnancies had a weak positive effect on BMD in premenopausal women. As compared with nonusers premenopausal women who had used alcohol showed a slightly decreased BMD of Ward's triangle. In postmenopausal women there was a positive correlation between alcohol intake and BMD.     

Bone mineral density in feline mucopolysaccharidosis VI measured using dual-energy X-ray absorptiometry

Dual-energy X-ray absorptiometry (DXA) was used to determine the in vivo bone mineral density (BMD) and bone mineral content (BMC) of lumbar vertebrae in six cats affected with the inherited lysosomal storage disease mucopolysaccharidosis VI (MPS VI). DXA was also performed on MPS cats that had a bone marrow transplant (BMT) and total body irradiation (TBI) (MPS+BMT;n=7), normal cats that had a bone marrow transplant, and TBI (control+BMT; n=8) and normal cats (control; n=14). Following euthanasia, one of the lumbar vertebrae that had been scanned (L5) was harvested and bone volume (BV/TV%) was determined by histomorphometry. The in vivo BMD and BMD measurements were compared with the BV/TV%. There was a greater BMD and BMC in the MPS+BMT cats compared with the MPS cats but the difference was not statistically significant. However, there was a greater BV/TV% in the MPS+BMT cats compared with the MPS cats and the difference was significant (P=0.0152). Correlation between the noninvasive in vivo DXA measurements of BMD and BMC and the BV/TV% was significant (r ²=0.767, P<0.0001; r ²=0.504, P<0.0001). Noninvasive in vivo DXA was a rapid and precise method for measuring the lumbar BMD and BMC in cats and it correlated well with histomorphometric determination of bone mass. Further, the response of inherited storage diseases such as MPS VI to therapy, such as BMT, could be monitored in a longitudinal fashion using DXA.     

Evaluation of lumbar spine bone mineral density in the anteroposterior and lateral projections by dual-energy X-ray absorptiometry.

Dual-energy x-ray absorptiometry (DXA) is an established method for estimating bone mineral density (BMD) of the lumbar spine. In a prospective study, the sensitivity of BMD measurements between anteroposterior and lateral projections were evaluated in 204 postmenopausal women based on their DXA analysis. Patients were divided into two groups according to the absence or presence of lumbar scoliosis. Lateral projection DXA measurements were more sensitive than AP projection measurements for early detection of bone loss in postmenopausal women. Lateral projection DXA analysis is not recommended in spines with lumbar scoliosis.     

Discordance in lumbar bone mineral density measurements by quantitative computed tomography and dual-energy X-ray absorptiometry in postmenopausal women: a prospective comparative study

Background ContextLevel-specific lumbar bone mineral density (BMD) evaluation of a single vertebral body can provide useful surgical planning and osteoporosis management information. Previous comparative studies have primarily focused on detecting spinal osteoporosis but not at specific levels.PurposeTo compare the detection rate of lumbar osteoporosis between quantitative computed tomography (QCT) and dual-energy X-ray absorptiometry (DXA); to explore and analyze the distribution models of QCT-derived BMD and DXA T-score at the specific levels; and to evaluate the diagnostic accuracy of level-specific BMD thresholds for the prediction of osteoporotic vertebral compression fracture (OVCF) in postmenopausal women.Study Design/SettingA comparative analysis of prospectively collected data comparing QCT-derived BMD with DXA T-score.Patient SampleA total of 296 postmenopausal women who were referred to the spine service of a single academic institution were enrolled.Outcome MeasuresQCT-derived BMD and DXA T-score at specific levels, with or without osteoporotic vertebral compression fracture.MethodsPostmenopausal women who underwent QCT and DXA within a week of admission from May 2019 to June 2022 were enrolled. The diagnostic criteria for osteoporosis recommended by the World Health Organization and the American College of Radiology were used for lumbar osteoporotic diagnosis. To evaluate differences in lumbar BMD measurements at specific levels, a threshold of T score=-2.5 and QCT-derived BMD = 80 mg/cm³ were used to categorize level-specific lumbar BMD into low and high BMD. Disagreements in BMD categorization between DXA and QCT were classified as a minor or major discordance based on the definition by Woodson. Data between QCT and DXA were visualized in a stacked bar plot and analyzed. Correlations between DXA and QCT at the specific levels were evaluated using Pearson's linear correlation and scatter plots. Curve fitting of BMD distribution, receiver operating characteristic (ROC) and area under the curve (AUC) for each single vertebral level was performed.ResultsOf the 296 patients, QCT diagnosed 61.1% as osteoporosis, 30.4% as osteopenia and 8.4% as normal. For those screened with DXA, 54.1% of the patients had osteoporosis, 29.4% had osteopenia and 16.6% had normal BMD. Diagnoses were concordant for 194 (65.5%) patients. Of the other 102 discordant patients, 5 (1.7%) were major and 97 (32.8%) were minor. Significant correlations in level-specific BMD between DXA and QCT were observed (p<.001), with Pearson's correlation coefficients ranging from 0.662 to 0.728. The correlation strength was in the order of L1 > L2 > L3 > L4. The low BMD detection rate for QCT was significantly higher than that for DXA at the L3 and L4 levels (65% vs. 47.9% and 68.1% vs 43.7, respectively, p<.001). Patients with OVCF showed significantly lower QCT-derived BMD (47.2 mg/cm³ vs. 83.2 mg/cm³, p<.001) and T-score (-3.39 vs. -1.98, p<.001) than those without OVCF. Among these patients, 82.8% (101/122) were diagnosed with osteoporosis by QCT measurement, while only 74.6% (91/122) were diagnosed by DXA. For discrimination between patients with and without OVCF, QCT-derived BMD showed better diagnosed performance (AUC range from 0.769 to 0.801) than DXA T-score (AUC range from 0.696 to 0.753).ConclusionQCT provided a more accurate evaluation of lumbar osteoporosis than DXA. The QCT-derived BMD measurements at a specific lumbar level have a high diagnostic performance for OVCF.     

Bone mineral density assessment: comparison of dual-energy X-ray absorptiometry measurements at the calcaneus, spine, and hip.

It is widely accepted that bone mineral density (BMD) measurements obtained by dual-energy X-ray absorptiometry (DXA) at the spine, hip, and calcaneus predict fracture risk. Few published studies to date have examined the relationship between pDXA measurements at the calcaneus to those at the hip and spine. It has been demonstrated that T-score-based criteria cannot be universally applied to all skeletal sites and measurement technologies. Our goal was to define the calcaneal T-score threshold equivalent to low bone mass at the hip or spine. A total of 119 female patients between the ages of 33 and 76 yr of age were recruited at Boston University Medical Center for bone densitometry screening. Bone density measurements were obtained at the calcaneus using the portable Norland Apollo Densitometer (Norland Medical Systems, Fort Atkinson, WI) and at the hip and spine using the Norland Eclipse densitometer. By defining a pDXA T-score < or =-1 as a positive test and DXA scores < or =-1 as the presence of low bone mass, we obtained a specificity of 100% and a sensitivity of 73% (positive predictive value 100% and negative predictive value 80%) in detecting low bone mass at the femoral neck in women over age 65 yr. In women between 40 and 65 yr of age, we obtained a sensitivity of 50% and a specificity of 93% (positive predictive value 93% and negative predictive value 50%) in detecting low bone mass at the femoral neck. In women less than 40 yr of age, we obtained a sensitivity of 13% and a specificity of 100% (positive predictive value 100% and negative predictive value 75%) in detecting low bone mass at the femoral neck. From receiver operating characteristic curves, a calcaneal T-score < or =0.0 detects those with a T-score < or =-1 at the femoral neck and lumbar spine with 100% and 85% sensitivity, respectively. Peripheral DXA of the calcaneus is a sensitive and specific test to diagnose low bone mass in women over 65 yr of age. In women under 65 yr of age, this modality, though not as sensitive, is specific in detecting low bone mass. We conclude that a pDXA calcaneal T-score < or =0 is highly sensitive in predicting osteopenia and osteoporosis at the femoral neck and lumbar spine.     

Bone mineral and soft tissue measurements by dual-energy X-ray absorptiometry during growth

There have been several previous compilations of reference ranges of total body bone mineral measured by dual-energy X-ray absorptiometry (DXA) in children and young adults during growth, but little attempt to compare the results or to consider differences arising from the use of instruments from different manufacturers. We measured bone mineral and soft tissue in 216 girls, aged 11-17 years, using a Hologic scanner. Our results were compared with those from four other studies, all performed on white subjects, but in different countries, and including measurements performed with Hologic, Lunar, and Norland scanners. The general pattern of bone growth with age was very similar in all the studies. Quantitative differences could largely be accounted for by known differences of calibration of DXA scanners from the different manufacturers. When bone mass was plotted against lean or total mass instead of age there were also close similarities. An apparent difference between boys and girls in one study was shown to be due to differences in soft tissue composition, rather than different patterns of bone growth. Conclusions from this apparent difference concerning the effect of estrogen at puberty were shown to be unwarranted.